Health Maintenance Consensus for Adults With Inflammatory Bowel Disease
- PMID: 34279600
- PMCID: PMC8861367
- DOI: 10.1093/ibd/izab155
Health Maintenance Consensus for Adults With Inflammatory Bowel Disease
Abstract
Background: With the management of inflammatory bowel disease (IBD) becoming increasingly complex, incorporating preventive care health maintenance measures can be challenging. The aim of developing these updated recommendations is to provide more specific details to facilitate their use into a busy clinical practice setting.
Method: Fifteen statements were formulated with recommendations regarding the target, timing, and frequency of the health maintenance interventions in patients with IBD. We used a modified Delphi method and a literature review to establish a consensus among the panel of experts. The appropriateness of each health maintenance statement was rated on a scale of 1 to 5 (1-2 as inappropriate, and 4-5 as appropriate) by each panelist. Interventions were considered appropriate, and statements were accepted if ≥80% of the panelists agreed with a score ≥4.
Results: The panel approved 15 health maintenance recommendations for adults with IBD based on the current literature and expert opinion. These recommendations include explicit details regarding specific screening tools, timing of screening, and vaccinations for adults with IBD.
Conclusions: Patients with IBD are at an increased risk for infections, malignancies, and other comorbidities. Given the complexity of caring for patients with IBD, this focused list of recommendations can be easily incorporated in to clinical care to help eliminate the gap in preventative care for patients with IBD.
Keywords: Crohn’s disease; cancer screening; inflammatory bowel disease; ulcerative colitis; vaccination.
© 2021 Crohn’s & Colitis Foundation. Published by Oxford University Press. All rights reserved. For permissions, please e-mail: journals.permissions@oup.com.
Similar articles
-
Appropriateness of immunosuppressive drugs in inflammatory bowel diseases assessed by RAND method: Italian Group for IBD (IG-IBD) position statement.Dig Liver Dis. 2005 Jun;37(6):407-17. doi: 10.1016/j.dld.2004.12.013. Dig Liver Dis. 2005. PMID: 15893279 Review.
-
SURGICAL MANAGEMENT OF ADULT CROHN'S DISEASE AND ULCERATIVE COLITIS PATIENTS: A CONSENSUS FROM THE BRAZILIAN ORGANIZATION OF CROHN'S DISEASE AND COLITIS (GEDIIB).Arq Gastroenterol. 2023 Mar 24;59(suppl 1):1-19. doi: 10.1590/S0004-2803.2022005S1-01. eCollection 2023. Arq Gastroenterol. 2023. PMID: 36995887
-
Defining the Roles of Inflammatory Bowel Disease Clinical Pharmacists in the United States: A Systematic Review and National RAND/UCLA Consensus.Inflamm Bowel Dis. 2024 Jun 3;30(6):950-959. doi: 10.1093/ibd/izad143. Inflamm Bowel Dis. 2024. PMID: 37650888 Free PMC article.
-
BRAZILIAN CONSENSUS ON THE MANAGEMENT OF INFLAMMATORY BOWEL DISEASES IN PEDIATRIC PATIENTS: A CONSENSUS OF THE BRAZILIAN ORGANIZATION FOR CROHN'S DISEASE AND COLITIS (GEDIIB).Arq Gastroenterol. 2023 Mar 24;59(suppl 1):85-124. doi: 10.1590/S0004-2803.2022005S1-04. eCollection 2023. Arq Gastroenterol. 2023. PMID: 36995890
-
The management of patients with inflammatory bowel disease-associated spondyloarthritis: Italian Group for the Study of Inflammatory Bowel Disease (IG-IBD) and Italian Society of Rheumatology (SIR) recommendations based on a pseudo-Delphi consensus.Autoimmun Rev. 2024 May;23(5):103533. doi: 10.1016/j.autrev.2024.103533. Epub 2024 Mar 22. Autoimmun Rev. 2024. PMID: 38521214 Review.
Cited by
-
Consensus Statements on Assessments and Vaccinations Prior to Commencement of Advanced Therapies for the Treatment of Inflammatory Bowel Diseases.Aliment Pharmacol Ther. 2025 Jan;61(1):132-144. doi: 10.1111/apt.18318. Epub 2024 Oct 10. Aliment Pharmacol Ther. 2025. PMID: 39387155 Free PMC article.
-
The Impact of Concomitant Hypothyroid Disease on the Course of Inflammatory Bowel Disease.Dig Dis Sci. 2025 May;70(5):1854-1863. doi: 10.1007/s10620-025-08956-6. Epub 2025 Mar 1. Dig Dis Sci. 2025. PMID: 40025310
References
-
- Dahlhamer JM, Zammitti EP, Ward BW, et al. . Prevalence of inflammatory bowel disease among adults aged ≥18 years - United States, 2015. MMWR Morb Mortal Wkly Rep. 2016;65:1166–1169. - PubMed
-
- Sinclair JA, Wasan SK, Farraye FA. Health maintenance in the inflammatory bowel disease patient. Gastroenterol Clin North Am. 2012;41:325–337. - PubMed
-
- Navabi S, Gorrepati VS, Yadav S, et al. . Influences and impact of anxiety and depression in the setting of inflammatory bowel disease. Inflamm Bowel Dis. 2018;24:2303–2308. - PubMed
-
- Chan W, Shim HH, Lim MS, et al. . Symptoms of anxiety and depression are independently associated with inflammatory bowel disease-related disability. Dig Liver Dis. 2017;49:1314–1319. - PubMed
-
- Nunes T, Etchevers MJ, Domènech E, et al. ; Tobacco-Eneida Study Group of GETECCU . Smoking does influence disease behaviour and impacts the need for therapy in Crohn’s disease in the biologic era. Aliment Pharmacol Ther. 2013;38:752–760. - PubMed
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Miscellaneous